George Soros's position in Neurocrine Biosciences is currently worth $23.1 Million. That's 0.73% of their equity portfolio (38th largest holding). The first Neurocrine Biosciences trade was made in Q4 2010. Since then George Soros bought shares twelve more times and sold shares on nine occasions. The investor's estimated purchase price is $23.5 Million, resulting in a loss of 1.6%.